SCHEMBL4786389

SCHEMBL4786389

ClCC1(Cl)Nc2ccc(Cl)cc2N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 2/20 0.50
▸ LIMK1 P53667 1/20 0.50
▸ CES1 P23141 2/20 0.36
▸ TGM2 P21980 1/20 0.36
▸ AHR P35869 2/20 0.35
▸ CMA1 P23946 1/20 0.35
▸ BCHE P06276 2/20 0.34
▸ ACHE P22303 2/20 0.34
▸ NOX1 Q9Y5S8 2/20 0.34
▸ PDE7A Q13946 2/20 0.33
▸ HTR3A P46098 3/20 0.33
▸ HTR5A P47898 3/20 0.33
▸ ADRA2A P08913 2/20 0.33
▸ ADRA2B P18089 2/20 0.33
▸ ADRA2C P18825 2/20 0.33
▸ DRD4 P21917 2/20 0.33
▸ HTR1D P28221 2/20 0.33
▸ HTR2A P28223 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ HTR7 P34969 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11386072 0.72 CHEK1 (0.55) CHEK1LIMK1CES1TGM2AHR
SCHEMBL13868943 0.68 CHEK1 (0.59) CHEK1LIMK1CES1TGM2AHR
SCHEMBL13868946 0.68 CHEK1 (0.59) CHEK1LIMK1CES1TGM2AHR
SCHEMBL23092730 0.68 CHEK1 (0.39) CHEK1LIMK1CES1TGM2AHR
Fluoride SCHEMBL3292595 0.66 — —
SCHEMBL23092724 0.66 CHEK1 (0.37) CHEK1LIMK1CES1TGM2NOX1
SCHEMBL15415495 0.66 CHEK1 (0.40) CHEK1LIMK1AHRCMA1PDE7A
SCHEMBL13826690 0.63 CHEK1 (0.69) CHEK1LIMK1CES1TGM2AHR
SCHEMBL9076137 0.62 CHEK1 (0.44) CHEK1LIMK1CES1TGM2AHR
SCHEMBL22431926 0.60 CHEK1 (0.41) CHEK1LIMK1CES1TGM2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008080015-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2008-07-03 — — WO disclosed
Send feedback